OB/GYN & Women’s Health

FDA Panel Reviews SSRI Use During Pregnancy: Balancing Fetal Risks and Maternal Mental Health

By MedXY 07/29/2025

An FDA expert panel debates the risks and benefits of SSRI antidepressants in pregnancy, emphasizing the need to weigh untreated depression risks against potential drug-related fetal outcomes.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Beyond hysterectomy: Modern approaches to managing uterine fibroids

By Dr.Paul 07/29/2025

Background: Common Yet MisunderstoodUterine fibroids—also known as leiomyomas—are the most prevalent benign tumors in women…

OB/GYN & Women's Health Specialties Wellness & Lifestyle

How Air Pollution in Pregnancy May Shape Your Child’s Weight: Between Prenatal PM2.5 Exposure and Childhood Obesity

By MedXY 07/29/2025

Emerging research reveals that prenatal exposure to fine particulate air pollution (PM2.5) may significantly increase a child’s risk of developing obesity, spotlighting pregnancy as a critical window for future health.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Removing Out-of-Pocket Costs Increases Access to 3D Mammograms

By MedXY 07/29/2025

Eliminating a $45 fee for advanced breast cancer screening technology improves access and reduces health disparities, according to recent research.

Diabetes & Endocrinology OB/GYN & Women's Health Specialties Wellness & Lifestyle

Revolutionizing Diabetes Management in Pregnancy with Hybrid Closed-Loop Technology

By MedXY 07/29/2025

A groundbreaking trial highlights how hybrid closed-loop systems improve glycemic control for pregnant women with type 1 diabetes, offering enhanced maternal and fetal health outcomes.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Gut Microbiota and Pregnancy Risks: the Connection in Polycystic Ovary Syndrome

By MedXY 07/29/2025

Scientific findings link imbalances in gut microbiota and metabolic markers to pregnancy complications in women with PCOS.

OB/GYN & Women's Health Oncology Specialties Wellness & Lifestyle

Understanding Hormone Therapy and Breast Cancer Risk in Younger Women

By MedXY 07/29/2025

Recent research highlights that estrogen-only hormone therapy may reduce breast cancer risk in women under 55, while combined estrogen-progestin therapy could increase risk.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Pregnancy Complications and Long-Term Stroke Risk: A Hidden Connection

By MedXY 07/29/2025

A study reveals that complications during pregnancy, such as preeclampsia, gestational diabetes, and preterm birth, are linked to an increased risk of stroke years later.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Endometriosis and Pregnancy: Insights from a Landmark Study

By MedXY 07/29/2025

A 30-year study reveals women with endometriosis-related infertility have higher pregnancy rates compared to other infertility causes, emphasizing the importance of early diagnosis and tailored treatments.

Diabetes & Endocrinology OB/GYN & Women's Health Specialties Wellness & Lifestyle

Gut Microbiota and Gestational Diabetes: A Critical Connection

By MedXY 07/29/2025

New research highlights links between gut microbiota composition and gestational diabetes, offering potential for early detection and personalized treatment strategies.

OB/GYN & Women's Health Oncology Specialties Wellness & Lifestyle

Advancing Access to Cervical Cancer Screening: The Promise of Self-Collection Methods

By MedXY 07/29/2025

Self-collection devices for cervical cancer screening offer a safe, effective, and preferred alternative to traditional methods, increasing accessibility and compliance.

OB/GYN & Women's Health Oncology Specialties Wellness & Lifestyle

Mail-in HPV Self-Tests Double Cervical Cancer Screening Rates

By MedXY 07/29/2025

Mail-in HPV self-collection kits significantly increase cervical cancer screening participation, offering a promising tool to enhance early detection and preventive care.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Evaluating HPV Vaccination Schedules: A New Perspective on Booster Doses

By MedXY 07/29/2025

Recent research suggests that a 2-dose HPV vaccine regimen offers similar long-term protection against HPV-16 and HPV-18 as the 2+1-dose regimen, challenging the necessity of booster doses.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

State Abortion Laws and Maternal Health: Examining the Impact on High-Risk Pregnancies

By MedXY 07/29/2025

Restrictive abortion legislation significantly increases maternal complications in high-risk pregnancies, highlighting urgent public health concerns.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Evaluating the Effectiveness of USPSTF Preeclampsia Guidelines for Aspirin Prophylaxis

By MedXY 07/29/2025

A recent study questions the specificity of USPSTF guidelines for preeclampsia risk assessment, highlighting challenges in identifying patients truly at high risk and ensuring targeted aspirin prophylaxis.

Cardiology OB/GYN & Women's Health Specialties Wellness & Lifestyle

Hypertensive Disorders in Pregnancy: Impact on Breastfeeding and Maternal Health

By MedXY 07/29/2025

Hypertensive disorders during pregnancy affect breastfeeding initiation and duration, highlighting the need for tailored support for affected mothers.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Understanding Placenta Accreta Spectrum: Gaps in Global Guidelines and the Path Forward

By MedXY 07/29/2025

Global variations in placenta accreta spectrum (PAS) management guidelines highlight the need for improved standardization and research, especially in resource-limited settings.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

SSRIs and Pregnancy: Navigating the Risks, Benefits, and Ongoing Debate

By MedXY 07/29/2025

A new FDA panel reignites debate over the safety and efficacy of antidepressant use during pregnancy, with experts weighing in on emerging research and practice recommendations.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

Rethinking Menopausal Hormone Therapy: Experts Urge FDA to Revise Outdated Warnings

By MedXY 07/29/2025

Leading experts call on the FDA to update boxed warnings on menopausal hormone therapies, arguing current labels are outdated and deter women from effective, safe treatments.

OB/GYN & Women's Health Specialties Wellness & Lifestyle

DM199 Shows Promise as a Potential Treatment for Preeclampsia

By MedXY 07/29/2025

DM199 has demonstrated safety and efficacy in reducing blood pressure among preeclampsia patients during a Phase 2 trial, offering hope for improved maternal and fetal outcomes.